4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-000174
Chief Accounting Officer gave up 3,268 shares (to pay taxes)
- Chief Accounting Officer acquired 56,980 shares (grant or award)
- Chief Accounting Officer acquired 9,420 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mossler Mark · Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-13 | Grant or award : show line 1 in the form | +56,980 | 75,184 | D | ||
| 2026-02-14 | Exercise or conversion : show line 2 in the form | +9,420 | 75,184 | D | ||
| 2026-02-14 | Shares withheld for taxes : show line 3 in the form | −3,268 | $1.89 | $6,177 | 71,916 | D |
Loading xslF345X05/wk-form4_1771452272.xml…